INDICATIONS AND USAGE
Synagis is a respiratory syncytial virus (RSV) F protein inhibitor monoclonal antibody indicated for the prevention of serious lower respiratory tract disease caused by RSV in children at high risk of RSV disease.
• Safety and efficacy were established in children with bronchopulmonary dysplasia (BPD), infants with a history of premature birth (less than or equal to 35 weeks gestational age), and children with hemodynamically significant congenital heart disease (CHD).
• The safety and efficacy of Synagis have not been established for treatment of RSV disease.
DOSAGE FORMS & STRENGTHS
Single-dose liquid solution vials: 50 mg per 0.5 mL and 100 mg per 1 mL.
Manufactured By: MedImmune
Prescribing Information URL: Click Here
FDA approved Anti-Cancer medicine SYNAGIS (palivizumab) injection is available upon request. To get best retail price of SYNAGIS (palivizumab) injection in India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected] For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with pulmonologist.
Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused by respiratory syncytial virus (RSV) infections. It is recommended for infants that are high-risk because of prematurity or other medical problems such as congenital heart disease.
Palivizumab targets the fusion protein of RSV, inhibiting its entry into the cell and thereby preventing infection. Palivizumab was approved for medical use in 1998.
You can order palivizumab injection through Medvitaz Pharma Solutions under Named Patient Program (NPP). Medvitaz provides patients and physicians access to commercialy approved medicines that are not available to them in their own country. Medvitaz objectives is to make quality medicines available at affordable prices for patients and physicians. To get best retail price/cost of palivizumab injection in India, Call 8750295029 or Email [email protected]. FDA approved drugs of Australia, Canada, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.
Head of Operations
The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.
Contact us and we will reply as soon as possible!
MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.
